Why is Tatva Chintan falling/rising?

As of 11-Sep, Tatva Chintan Pharma Chem Ltd is currently priced at 1,009.60, reflecting an increase of 1.6, or 0.16%. Despite this slight uptick, the stock has shown a decline of 2.98% over the past week and 2.94% over the past month, indicating a downward trend in the short term. Today's performance suggests that the stock has outperformed its sector by 0.3%. However, it is noteworthy that the stock's delivery volume has significantly decreased by 64.45% compared to the 5-day average, which may indicate falling investor participation. The company maintains a low debt-to-equity ratio of 0.07 times, which is a positive factor, but the overall performance over longer periods shows a substantial decline of 59.32% over three years, contrasting with the benchmark's growth.
In the broader market context, the Sensex has increased by 1.03% over the past week and 1.17% over the past month, while Tatva Chintan's recent performance has lagged behind these benchmarks. Year-to-date, the stock has outperformed the Sensex with a gain of 14.36% compared to the index's 4.36%, but the recent short-term declines suggest that investor sentiment may be shifting. The stock's moving averages indicate mixed signals, being higher than the 100-day and 200-day averages but lower than the shorter-term averages, which could reflect volatility in investor confidence. Overall, while there are some positive indicators, the recent trends and declining participation may contribute to a cautious outlook for the stock.